Jun 8, 2021 | Archived
Gaithersburg, MD (June 8, 2021) – miRecule, Inc. (“miRecule”), an emerging biotech company focused on the development of cutting-edge RNA therapeutics, announced the hiring of Fu-An Kang, Ph.D. to serve as its Vice President of Research. Dr. Kang joins miRecule...
May 27, 2021 | Archived
Read the full story here: Global News...
Dec 16, 2020 | Archived
Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer – Clinical Cancer Research
Dec 16, 2020 | Archived
miRecule closes Seed Round at the second annual BioHealth Capital Region Investment Conference – BioBuzz
Dec 16, 2020 | Archived
miRecule, Inc., is developing a novel treatment for FSHD – FSHD Society
